Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-06-26T05:04:32.317Z Has data issue: false hasContentIssue false

13 - Developmental Pharmacology

The Neonate

from Section 2 - Newborn and Infant Anesthesia

Published online by Cambridge University Press:  09 February 2018

Mary Ellen McCann
Affiliation:
Harvard Medical School, Boston, MA, USA
Christine Greco
Affiliation:
Harvard Medical School, Boston, MA, USA
Kai Matthes
Affiliation:
Harvard Medical School, Boston, MA, USA
Get access

Summary

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Crawford, J, Terry, M, Rourke, G. Simplification of drug dosage calculation by application of the surface area principle. Pediatrics. 1950;5:783–90.Google Scholar
2.Holliday, M, Segar, W. The maintenance need for water in parenteral fluid therapy. Pediatrics. 1957;19:823–32.Google Scholar
3.Anderson, B, Holford, N. Tips and traps analyzing pediatric PK data. Pediatric Anesthesia. 2011;21:222–37.Google Scholar
4.Robiquet, T. Rapport sur un memoire adresse a l’Academie royale de medecine par MM Sarrus et Rameaux. Bull Acad R Med. 1839;3:1094.Google Scholar
5.Brody, S: Bioenergetics and Growth: With Special Reference to the Efficiency Complex. New York: Reinhold Publishing Corporation; 1945.Google Scholar
6.Rigby-Jones, AE, Sneyd, JR. Pharmacokinetics and pharmacodynamics-is there anything new? Anesthesia. 2012;67:111.CrossRefGoogle ScholarPubMed
7.Anderson, B, Allegaert, K, Holford, N. Population clinical pharmacology of children: modelling covariate effects. Eur J Pediatr. 2006;165:819–29.Google Scholar
8.Edginton, A. Knowledge-driven approaches for the guidance of first-in-children dosing. Pediatric Anesthesia. 2011;21:206–13.Google Scholar
9.Rhodin, M, Anderson, B, Peters, A, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol. 2009;24:6776.Google Scholar
10.de Wildt, S, Kearns, G, Leeder, J, van den Anker, J. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet. 1999;37:485505.Google Scholar
11.Cella, M, Knibbe, C, Danhof, M, Pascua, OD. What is the right dose for children? Br J Clin Pharmacol. 2010;70:597603.Google Scholar
12.Kearns, G, Abdel-Rahman, S, Alander, S, et al. Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157–67.CrossRefGoogle ScholarPubMed
13.Marsh, D, Hatch, D, Fitzgerald, M, et al. Opioid systems and the newborn. Br J Anaes. 1997;79:787–95.CrossRefGoogle ScholarPubMed
14.Klitzner, T, Friedman, W. A diminished role for the sarcoplasmic reticulum in newborn myocardial contraction: effects of ryanodine. Ped Res. 1989;26:98101.Google Scholar
15.Johnson, T, Rostami-Hodjegan, A. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice. Paediatr Anesth. 2011;21:291301.Google Scholar
16.Johnson, T, Rostami-Hodjegan, A, Tucker, G. Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children. Clin Pharmacokinet. 2006;45:931–56.Google Scholar
17.Keys, T. The History of Surgical Anesthesia. New York: Dover Publications; 1963.Google Scholar
18.Coté, CJ. Pediatric anesthesia. In: Miller, RD, Eriksson, LI, Fleisher, LA, et al., editors. Miller’s Anesthesia, 7th edn. Philadelphia, PA: Churchill Livingstone; 2010.Google Scholar
19.Vlajkovic, G, Sindjelic, R. Emergence delirium in children: many questions, few answers. Anesth Analg. 2007;4:8491.Google Scholar
20.Friedman, W. The intrinsic physiologic properties of the developing heart. Prog Cardiovasc Dis. 1972;15:87111.Google Scholar
21.Blanco, C, Dawes, G, Hanson, M. Carotid baroreceptors in fetal and newborn sheep. Ped Res. 1988;24:342–6.CrossRefGoogle ScholarPubMed
22.Friedman, W, George, B. Treatment of congestive heart failure by altering loading conditions of the heart. J Ped. 1985;106:697706.Google Scholar
23.Holden, K, Morgan, J, Krauss, A. Incomplete baroreceptor responses in newborn infants. Amer J Perinat. 1985;2:31–4.Google Scholar
24.Gournay, V, Drouin, E, Rozé, J. Development of baroreflex control of heart rate in preterm and full term infants. Arch Dis Child Fetal Neonatal Ed. 2002;86: F151–4.Google Scholar
25.Patton, D, Hanna, B. Postnatal maturation of baroreflex heart rate control in neonatal swine. Can J Cardiol. 1994;10:233–8.Google Scholar
26.Holzman, R, van der Velde, M, Kaus, S, et al. Sevoflurane depresses myocardial contractility less than halothane during induction of anesthesia in children. Anesthesiology. 1996;85:1260–7.Google Scholar
27.Steur, R, Perez, R, De Lange, J. Dosage scheme for propofol in children under 3 years of age. Paediatr Anaesth. 2004;14:462–7.Google Scholar
28.Jacqz-Aigrain, E, Burtin, P. Clinical pharmacokinetics of sedatives in neonates. Clin Pharmacokinet. 1996;31:423–43.Google Scholar
29.Anderson, B, Allegaert, K. The pharmacology of anaesthetics in the neonate. Best Pract Res Clin Anaesth. 2010;24:419–31.Google Scholar
30.Pacifici, G. Clinical pharmacology of midazolam in neonates and children: effect of disease – a review. Int J Pediatr., 2014. doi: 10.1155/2014/309342.Google Scholar
31.de Wildt, S, Kearns, G, Hop, W, et al. Pharmacokinetics and metabolism of intravenous midazolam in preterm infants. Clin Pharmacol Ther. 2001;70:525–31.Google Scholar
32.Burtin, P, Jacqz-Aigrain, E, Girard, P, et al. Population pharmacokinetics of midazolam in neonates. Clin Pharmacol Ther. 1994;56:615–25.Google Scholar
33.Wermeling, D, Miller, J, Archer, S, Manaligod, J, Rudy, A. Bioavailability and pharmacokinetics of lorazaepam after intranasal, intravenous and intramuscular administration. J Clin Pharmacol. 2001;41:1225–31.Google Scholar
34.McDermott, C, Kowalczyk, A, Schnitzler, E, et al. Pharmacokinetics of lorazepam in critically ill neonates with seizures. J Pediatr. 1992;120:479–83.Google Scholar
35.Chrysostomou, C, Zeballos, T. Use of dexmedetomidine in a pediatric heart transplant patient. Pediatr Cardiol. 2005;26:651–4.CrossRefGoogle Scholar
36.Finkel, J, Johnson, Y, Quezado, Z. The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children. Crit Care Med. 2005;33:2110–12.Google Scholar
37.Ard, J, Doyle, W, Bekker, A. Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesth. 2003;15:263–6.Google Scholar
38.Tobias, J, Berkenbosch, J. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. J Neurosurg Anesthesiol. 2003;15:263–6.Google Scholar
39.Berkenbosch, J, Tobias, J. Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med. 2003;4:203–5.Google Scholar
40.Chrysostomou, C, Schulman, S, Castellanos, M, et al. A phase II/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J Pediatr. 2014;164:276–82.Google Scholar
41.Potts, A, Warman, G, Anderson, B. Dexmedetomidine disposition in children: a population analysis. Ped Anaesth. 2008;18:722–30.Google Scholar
42.Talke, P, Richardson, C, Scheinin, M, Fisher, D. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg. 1997;85:1136–42.CrossRefGoogle ScholarPubMed
43.Talke, P, Chen, R, Thomas, B, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000;90:834–9.Google Scholar
44.Hsu, Y, Cortinez, L, Robertson, K, et al. Dexmedetomidine pharmacodynamics: part I. Anesthesiology. 2004;101:1066–76.Google Scholar
45.Cortinez, L, Hsu, Y, Sum-Ping, S, et al. Dexmedetomidine pharmacodynamics: part II. Anesthesiology. 2004;101:1077–83.Google Scholar
46.Petroz, G, Sikich, N, James, M, et al. A phase I, two-center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology. 2006;105:1098–110.Google Scholar
47.Berkenbosch, J, Wankum, P, Tobias, J. Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children. Pedatr Crit Care Med. 2005;6:435–9.Google Scholar
48.Bouwmeester, N, van den Anker, J, Hop, W, Anand, K, Tibboel, D. Age- and therapy-related effects on morphine requirements and plasma concentrations of morphine and its metabolites in postoperative infants. Br J Anaesth. 2003;90:642–52.Google Scholar
49.Bouwmeester, N, Anderson, B, Tibboel, D, Holford, N. Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. Br J Anaesth. 2004;92:208–17.Google Scholar
50.Tegeder, I, Lotsch, J, Geisslinger, G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinetics. 1999;37:1740.Google Scholar
51.Davis, P, Wilson, A, Siewers, R. The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair. Anesth Analg. 1999;89:904–8.Google Scholar
52.Ross, A, Davis, P, Dear, G, et al. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg. 2001;93:1393–401.Google Scholar
53.Welzing, L, Roth, B. Experience with remifentanil in neonates and infants. Drugs. 2006;66:1339–50.Google Scholar
54.Greeley, W, de Bruijn, N, Davis, D. Sufentanil pharmacokinetics in pediatric cardiovascular patients. Anesth Analg. 1987;66:1067–72.Google Scholar
55.Lundeberg, S, Roelofse, J. Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice. Paediatr Anaesth. 2011;21:274–9.Google Scholar
56.Pokela, M, Ryhanen, P, Koivisto, M, Olkkola, K, Saukkonen, A. Alfentanil-induced rigidity in newborn infants. Anesth Analg. 1992;75:252–7.Google Scholar
57.Anderson, B, van Lingen, R, Hansen, T, Lin, Y, Holford, N. Acetaminophen developmental pharmacokinetics in premature neonates and infants: a pooled population analysis. Anesthesiology. 2002;96:1336–45.Google Scholar
58.Allegaert, K, Naulaers, G, Vanhaesebrouck, S, Anderson, B. The paracetamol concentration-effect relation in neonates. Pediatric Anesthesia. 2013;23:4550.Google Scholar
59.Playfor, S, Jenkins, I, Boyles, C, et al. Consensus guidelines for sustained neuromuscular blockade in critically ill children. Pediatr Anesth. 2007;17:881–7.Google Scholar
60.Martin, L, Bratton, S, O’Rourke, P. Clinical uses and controversies of neuromuscular blocking agents in infants and children. Crit Care Med.. 1999;27:1358–68.Google Scholar
61.Martyn, J, White, D, Gronert, G, Jaffe, R, Ward, J. Up-and-down regulation of skeletal muscle acetylcholine receptors. Anesthesiology. 1992;76:822–43.Google Scholar
62.Meakin, G, McKiernan, E, Morris, P, Baker, R. Dose–reponse curves for suxamethonium in neonates, infants and children. Br J Anaesth. 1989;62:655–8.CrossRefGoogle Scholar
63.Hospira Inc. Succinylcholine chloride IV injection [Package insert]. Lake Forest, IL, Hospira, Inc, 2005Google Scholar
64.Goudsouzian, N, Ryan, J, Savarese, J. The neuromuscular effects of pancuronium in infants and children. Anesthesiology. 1974;41:95–8.Google Scholar
65.Meretoja, O, Wirtavuori, K, Neuvonen, P. Age-dependence of the dose–response curve of vecuronium in pediatric patients during balanced anesthesia. Anesth Analg. 1988;67:21–6.Google Scholar
66.Fisher, D, Castagnoli, K, Miller, R. Vecuronium kinetics and dynamics in anesthetized infants and children. Clin Pharmacol Ther. 1985;37:402–6.CrossRefGoogle ScholarPubMed
67.Foldes, F, Nagashima, H, Nguyen, H, et al. The neuromuscular effects of ORG9426 in patients receiving balanced anesthesia. Anesthesiology. 1991;75:191–6.Google Scholar
68.Woelfel, S, Brandom, B, Cook, D, Sarner, J. Effects of bolus administration of ORG-9426 in children during nitrous oxide–halothane anesthesia. Anesthesiology. 1992;76:939–42.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×